Viewing nowCombinationSupia Tablet 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Daehwa Pharmaceutical Co., Ltd.

MFDS item code 201706345 · Approved 2017.07.31 · Insurance code 645604910
Treatment of essential hypertension not controlled with monotherapy
Patients with essential hypertension may require additional treatment when adequate blood pressure control is not achieved with monotherapy using telmisartan or amlodipine. This medication helps to steadily lower blood pressure and prevent cardiovascular complications. Therefore, it is used for adequate blood pressure control and is effective in managing blood pressure.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the medicine be taken at the same time every day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before starting this medicine; however, direct switching to this medicine may be considered when blood pressure is not adequately controlled with the individual components, as follows: - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose. (See section “3. Patients Requiring Caution”) In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be initiated at a low dose and the dose increased gradually.
Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This medication can pose serious risks to the fetus when taken during pregnancy, especially in the second and third trimesters; therefore, it should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with certain conditions, such as severe liver impairment, left ventricular outflow obstruction, severe hypotension, cardiac shock, or unstable heart failure following acute myocardial infarction. Additionally, it is also safe not to take this medication during breastfeeding. Caution should be exercised when administering this medication to patients with primary aldosteronism, aortic and mitral stenosis, liver impairment, active gastrointestinal disorders, renovascular hypertension, kidney failure requiring dialysis, and elderly patients. Common side effects upon administration include dizziness and peripheral edema, while rare cases might include fainting or severe allergic reactions. Since this medication lowers blood pressure, it is essential to consult a doctor immediately if symptoms of hypotension appear, and special attention is required for patients with depleted fluids or salt. There is a risk of hyperkalemia, so it is advisable to regularly monitor serum potassium levels. Patients with diminished kidney function should frequently monitor their kidney function and electrolyte status. This medication may interact with some drugs, so patients must inform healthcare providers if they are taking other medications. Taking this medication during pregnancy can result in serious fetal damage, thus it should be discontinued immediately if pregnancy is confirmed. During breastfeeding, this medication can be transmitted via breast milk, so it is safest not to take it. It is not recommended for pediatric patients as safety and efficacy have not been adequately established. For elderly patients, dosage adjustment is required, and care should be taken regarding the occurrence of side effects. In case of overdose, hypotension, dizziness, and in severe cases, shock may occur; immediate medical attention is necessary to receive appropriate treatment. This medication should be stored out of reach of children and should be taken immediately after opening the package.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light and should be stored in a container that protects it from light. Furthermore, it is important to maintain a temperature between 1 and 30 degrees Celsius while storing the medication. This helps maintain the medication's efficacy and prevents degradation.
White and light blue, double convex, oval-shaped tablet
30 tablets (10 tablets/PTPX3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Daehwa Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.